Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer
Sponsor: Mayo Clinic
Summary
This early phase I trial evaluates the impact of chemotherapy before surgery (neoadjuvant) on the peripheral blood immune phenotype in patients with operable breast cancer. Collecting blood and information from patients with breast cancer may help to understand how the immune system influences response to treatment, and how the immune system reacts to breast cancer treatment.
Official title: Evaluating the Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Patients With Operable Breast Cancer (ENHANCE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
38
Start Date
2021-06-09
Completion Date
2028-06-08
Last Updated
2026-02-25
Healthy Volunteers
No
Conditions
Interventions
Biospecimen Collection
Undergo blood and tissue collection
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States